Aptorum Group Ltd Stock Fundamentals

APM Stock  USD 0.71  0.04  5.97%   
Aptorum Group Ltd fundamentals help investors to digest information that contributes to Aptorum Group's financial success or failures. It also enables traders to predict the movement of Aptorum Stock. The fundamental analysis module provides a way to measure Aptorum Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptorum Group stock.
At this time, Aptorum Group's Minority Interest is very stable compared to the past year. As of the 28th of November 2024, Depreciation And Amortization is likely to grow to about 1.3 M, while Operating Income is likely to drop (11 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aptorum Group Ltd Company Shares Outstanding Analysis

Aptorum Group's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Aptorum Group Shares Outstanding

    
  3.81 M  
Most of Aptorum Group's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptorum Group Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Aptorum Shares Outstanding Historical Pattern

Today, most investors in Aptorum Group Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptorum Group's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Aptorum Group shares outstanding as a starting point in their analysis.
   Aptorum Group Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Aptorum Common Stock Shares Outstanding

Common Stock Shares Outstanding

4.53 Million

At this time, Aptorum Group's Common Stock Shares Outstanding is very stable compared to the past year.
Based on the latest financial disclosure, Aptorum Group Ltd has 3.81 M of shares currently outstending. This is 97.89% lower than that of the Biotechnology sector and 96.43% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.33% higher than that of the company.

Aptorum Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aptorum Group's current stock value. Our valuation model uses many indicators to compare Aptorum Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptorum Group competition to find correlations between indicators driving Aptorum Group's intrinsic value. More Info.
Aptorum Group Ltd is rated second in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Aptorum Group's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aptorum Group by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Aptorum Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptorum Group's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptorum Group could also be used in its relative valuation, which is a method of valuing Aptorum Group by comparing valuation metrics of similar companies.
Aptorum Group is currently under evaluation in shares outstanding category among its peers.

Aptorum Fundamentals

About Aptorum Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aptorum Group Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptorum Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptorum Group Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.1 M992.3 K
Total Revenue431.4 K701.1 K
Cost Of Revenue420.8 K718.3 K
Stock Based Compensation To Revenue 2.93  2.19 
Sales General And Administrative To Revenue 10.12  12.34 
Research And Ddevelopement To Revenue 12.05  11.00 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.10  0.09 
Ebit Per Revenue(24.39)(25.61)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Aptorum Group is a strong investment it is important to analyze Aptorum Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aptorum Group's future performance. For an informed investment choice regarding Aptorum Stock, refer to the following important reports:
Check out Aptorum Group Piotroski F Score and Aptorum Group Altman Z Score analysis.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.095
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.32)
Return On Equity
(0.37)
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.